Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Mohamed Moussaoui, Mouna Baassi, Soukayna Baammi, Hatim Soufi, Mohammed Salah, Rachid Daoud, Achraf EL Allali, M.E. Belghiti & Said Belaaouad. (2023) In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-17.
Read now
Read now
Robert Elsby, Hayley Atkinson, Philip Butler & Robert J. Riley. (2022) Studying the right transporter at the right time: an in vitro strategy for assessing drug-drug interaction risk during drug discovery and development. Expert Opinion on Drug Metabolism & Toxicology 18:10, pages 619-655.
Read now
Read now
Vanessa Martins, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton & Nicola Wilsher. (2022) A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica 52:8, pages 786-796.
Read now
Read now
Articles from other publishers (45)
Rosangela Montanaro, Francesco Maione & Vincenzo Brancaleone. 2023. Methods for Preclinical Evaluation of Bioactive Natural Products. Methods for Preclinical Evaluation of Bioactive Natural Products
280
292
.
Koichi Handa, Peter Wright, Saki Yoshimura, Michiharu Kageyama, Takeshi Iijima & Andreas Bender. (2023) Prediction of Compound Plasma Concentration–Time Profiles in Mice Using Random Forest. Molecular Pharmaceutics 20:6, pages 3060-3072.
Crossref
Crossref
Hiroaki Iwata. (2023) Application of <i>in Silico</i> Technologies for Drug Target Discovery and Pharmacokinetic Analysis. Chemical and Pharmaceutical Bulletin 71:6, pages 398-405.
Crossref
Crossref
R. Lock, P. J. H. Webborn, C. W. Vose & R. M. J. Ings. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
265
297
.
Timothy J. Carlson. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development
175
187
.
Hiroaki Iwata, Tatsuru Matsuo, Hideaki Mamada, Takahisa Motomura, Mayumi Matsushita, Takeshi Fujiwara, Kazuya Maeda & Koichi Handa. (2022) Predicting Total Drug Clearance and Volumes of Distribution Using the Machine Learning-Mediated Multimodal Method through the Imputation of Various Nonclinical Data. Journal of Chemical Information and Modeling 62:17, pages 4057-4065.
Crossref
Crossref
Cristian Vicson Gomes Pinheiro, Wildson Max Barbosa da Silva, João Pedro Viana Rodrigues, Yasmim Mendes Rocha, Maria Jania Teixeira, Ronaldo Nascimento de Oliveira, Natália Vasconcelos de Souza & Roberto Nicolete. (2021) Anti-Leishmania infantum in vitro effect of n-cyclohexyl-1,2,4-oxadiazole and its ADME/TOX parameters. Journal of Parasitic Diseases 46:2, pages 317-322.
Crossref
Crossref
Anna-Karin Sohlenius-Sternbeck & Ylva Terelius. (2022) Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work. Drug Metabolism and Disposition 50:2, pages 95-104.
Crossref
Crossref
Hiroaki Iwata, Ryosuke Kojima & Yasushi Okuno. 2022. Artificial Intelligence in Medicine. Artificial Intelligence in Medicine
635
643
.
David J. Wagner, Aixiang Xue, Guangnong Zhang, Eric Gosselin, Nakpangi Johnson & Eric T. Gangl. (2021) Generation of High-Quality Pharmacokinetic Data From Parallel Tail Vein Dosing And Bleeding in Non-cannulated Rats. Journal of Pharmaceutical Sciences 110:10, pages 3491-3499.
Crossref
Crossref
Patrick Schnider. 2021. The Medicinal Chemist's Guide to Solving ADMET Challenges. The Medicinal Chemist's Guide to Solving ADMET Challenges
1
15
.
Hiroaki Iwata, Tatsuru Matsuo, Hideaki Mamada, Takahisa Motomura, Mayumi Matsushita, Takeshi Fujiwara, Maeda Kazuya & Koichi Handa. (2021) Prediction of Total Drug Clearance in Humans Using Animal Data: Proposal of a Multimodal Learning Method Based on Deep Learning. Journal of Pharmaceutical Sciences 110:4, pages 1834-1841.
Crossref
Crossref
Haseeb Mughal, Han Wang, Matthew Zimmerman, Marc d. Paradis & Joel S. Freundlich. (2021) Random Forest Model Prediction of Compound Oral Exposure in the Mouse. ACS Pharmacology & Translational Science 4:1, pages 338-343.
Crossref
Crossref
Ioana Oprisiu & Susanne Winiwarter. 2021. Systems Medicine. Systems Medicine
208
222
.
Hiroaki Iwata, Ryosuke Kojima & Yasushi Okuno. 2020. Artificial Intelligence in Medicine. Artificial Intelligence in Medicine
1
9
.
Randy R. Miller, Maria Madeira, Harold B. Wood, Wayne M. Geissler, Conrad E. Raab & Iain J. Martin. (2020) Integrating the Impact of Lipophilicity on Potency and Pharmacokinetic Parameters Enables the Use of Diverse Chemical Space during Small Molecule Drug Optimization. Journal of Medicinal Chemistry 63:21, pages 12156-12170.
Crossref
Crossref
Kei-Xian Tan, Vidya N. Chamundeswari & Say Chye Joachim Loo. (2020) Prospects of kefiran as a food-derived biopolymer for agri-food and biomedical applications. RSC Advances 10:42, pages 25339-25351.
Crossref
Crossref
Wilson Z. Shou. (2020) Current status and future directions of high-throughput ADME screening in drug discovery. Journal of Pharmaceutical Analysis 10:3, pages 201-208.
Crossref
Crossref
Johan WernevikFredrik BergströmAnna NovénJohan HultheLinda FredlundDan AddisonJan HolmgrenPer-Erik StrömstedtErika RehnströmThomas Lundbäck. (2020) A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling. ASSAY and Drug Development Technologies 18:4, pages 157-179.
Crossref
Crossref
Xin Yang, Yifei Wang, Ryan Byrne, Gisbert Schneider & Shengyong Yang. (2019) Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. Chemical Reviews 119:18, pages 10520-10594.
Crossref
Crossref
Olivier Fardel, Amélie Moreau, Marc Le Vée, Claire Denizot & Yannick Parmentier. (2018) Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes. European Journal of Drug Metabolism and Pharmacokinetics 44:1, pages 13-30.
Crossref
Crossref
Paul Morgan, Dean G. Brown, Simon Lennard, Mark J. Anderton, J. Carl Barrett, Ulf Eriksson, Mark Fidock, Bengt Hamrén, Anthony Johnson, Ruth E. March, James Matcham, Jerome Mettetal, David J. Nicholls, Stefan Platz, Steve Rees, Michael A. Snowden & Menelas N. Pangalos. (2018) Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nature Reviews Drug Discovery 17:3, pages 167-181.
Crossref
Crossref
Phil Jeffrey & Scott Summerfield. 2017. Pharmacology for Chemists: Drug Discovery in Context. Pharmacology for Chemists: Drug Discovery in Context
316
342
.
Claus Bendtsen, Andrea Degasperi, Ernst Ahlberg & Lars Carlsson. (2017) Improving machine learning in early drug discovery. Annals of Mathematics and Artificial Intelligence 81:1-2, pages 155-166.
Crossref
Crossref
John M. Sanders, Douglas C. Beshore, J. Christopher Culberson, James I. Fells, Jason E. Imbriglio, Hakan Gunaydin, Andrew M. Haidle, Marc Labroli, Brian E. Mattioni, Nunzio Sciammetta, William D. Shipe, Robert P. Sheridan, Linda M. Suen, Andreas Verras, Abbas Walji, Elizabeth M. Joshi & Tjerk Bueters. (2017) Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles. Journal of Medicinal Chemistry 60:16, pages 6771-6780.
Crossref
Crossref
Linda Fredlund, Susanne Winiwarter & Constanze Hilgendorf. (2017) In Vitro Intrinsic Permeability: A Transporter-Independent Measure of Caco-2 Cell Permeability in Drug Design and Development. Molecular Pharmaceutics 14:5, pages 1601-1609.
Crossref
Crossref
Estelle Yau, Carl Petersson, Hugues Dolgos & Sheila Annie Peters. (2017) A comparative evaluation of models to predict human intestinal metabolism from nonclinical data. Biopharmaceutics & Drug Disposition 38:3, pages 163-186.
Crossref
Crossref
R.E. White. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
1
33
.
M.P. Gleeson & D. Montanari. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
64
93
.
Robert H. BradburyRowena CallisGregory R. CarrHuawei Chen, Edwin Clark, Lyman FeronSteve GlossopMark A. GrahamMaureen Hattersley, Chris JonesScott G. LamontGilles Ouvry, Anil PatelJoe Patel, Alfred A. RabowCraig A. RobertsStephen StokesNatalie StrattonGraeme E. WalkerLara WardDavid WhalleyDavid WhittakerGail WrigleyMichael J. Waring. (2016)
Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3
R
)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-
b
]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)
. Journal of Medicinal Chemistry 59:17, pages 7801-7817.
Crossref
Crossref
N. Gobeau, R. Stringer, S. De Buck, T. Tuntland & B. Faller. (2016) Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery. Pharmaceutical Research 33:9, pages 2126-2139.
Crossref
Crossref
Sheila Annie Peters, Christopher R. Jones, Anna-Lena Ungell & Oliver J. D. Hatley. (2016) Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models. Clinical Pharmacokinetics 55:6, pages 673-696.
Crossref
Crossref
Christopher R. Jones, Oliver J. D. Hatley, Anna-Lena Ungell, Constanze Hilgendorf, Sheila Annie Peters & Amin Rostami-Hodjegan. (2016) Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination. The AAPS Journal 18:3, pages 589-604.
Crossref
Crossref
Richard JA Goodwin & Peter JH Webborn. (2015) Future directions of imaging MS in pharmaceutical R&D. Bioanalysis 7:20, pages 2667-2673.
Crossref
Crossref
Susanne Winiwarter, Brian Middleton, Barry Jones, Paul Courtney, Bo Lindmark, Ken M. Page, Alan Clark & Claire Landqvist. (2015) Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time. Journal of Computer-Aided Molecular Design 29:9, pages 795-807.
Crossref
Crossref
Anna Nilsson, Richard J. A. GoodwinMohammadreza Shariatgorji, Theodosia Vallianatou, Peter J. H. WebbornPer E. Andrén. (2015) Mass Spectrometry Imaging in Drug Development. Analytical Chemistry 87:3, pages 1437-1455.
Crossref
Crossref
Susan M. Jenkins & Dawn D. Parker. 2015. Discovering and Developing Molecules with Optimal Drug-Like Properties. Discovering and Developing Molecules with Optimal Drug-Like Properties
141
175
.
Andreas Reichel & Philip Lienau. 2016. New Approaches to Drug Discovery. New Approaches to Drug Discovery
235
260
.
Marianne Vath, Lizbeth Gallagher, Wilson Shou, Harold Weller, Lisa Elkin & Jun Zhang. (2014) Development of an LC–MS/MS method for high throughput quantification of metformin uptake in transporter inhibition assays. Journal of Chromatography B 967, pages 211-218.
Crossref
Crossref
Bernard Testa. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
1
26
.
Peter JH Webborn. (2014) The role of pharmacokinetic studies in drug discovery: where are we now, how did we get here and where are we going?. Future Medicinal Chemistry 6:11, pages 1233-1235.
Crossref
Crossref
Andreas Reichel. 2014. Drug Delivery to the Brain. Drug Delivery to the Brain
339
374
.
Nathalie Rioux, Edith Bellavance, Hugo Poirier, Mariève Dupuis, Michel Garneau, Maria D. Ribadeneira & Jianmin Duan. (2013) A strategy to reduce biliary clearance in early drug discovery. Journal of Pharmacological and Toxicological Methods 68:3, pages 346-348.
Crossref
Crossref
Maaria Ginai, Robert Elsby, Christopher J. Hewitt, Dominic Surry, Katherine Fenner & Karen Coopman. (2013) The use of bioreactors as in vitro models in pharmaceutical research. Drug Discovery Today 18:19-20, pages 922-935.
Crossref
Crossref
H van de Waterbeemd & B Testa. 2013. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.